ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 55 filers reported holding ARALEZ PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 16,000 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 16,000 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 16,000 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 16,000 | -63.6% | 0.00% | – |
| Q3 2018 | $1,000 | -95.2% | 44,000 | -26.7% | 0.00% | – |
| Q2 2018 | $21,000 | +90.9% | 60,000 | +650.0% | 0.00% | – |
| Q1 2018 | $11,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -50.0% | 8,000 | -19.2% | 0.00% | – |
| Q3 2017 | $22,000 | +4.8% | 9,900 | -1.4% | 0.00% | – |
| Q2 2017 | $21,000 | 0.0% | 10,045 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | -51.2% | 10,045 | 0.0% | 0.00% | – |
| Q4 2016 | $43,000 | +13.2% | 10,045 | +24.9% | 0.00% | – |
| Q3 2016 | $38,000 | – | 8,045 | +5448.3% | 0.00% | – |
| Q2 2016 | $0 | – | 145 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management, LLC | 237,547 | $843,000 | 13.09% |
| JW Asset Management, LLC | 1,836,375 | $6,519,000 | 4.26% |
| DRILL CRAIG A | 339,300 | $1,205,000 | 3.04% |
| Tiger Legatus Capital Management, LLC | 1,275,000 | $4,526,000 | 1.80% |
| Broadfin Capital, LLC | 3,800,000 | $13,490,000 | 1.30% |
| Healthcare Value Capital, LLC | 175,000 | $621,000 | 0.91% |
| Kavi Asset Management, LP | 313,627 | $1,113,000 | 0.87% |
| Healthcare Value Capital, LLC | 100,000 | $355,000 | 0.52% |
| Elk Creek Partners, LLC | 1,392,746 | $4,944,000 | 0.37% |
| Par Capital Management | 5,365,000 | $19,046,000 | 0.30% |